IL215195A0 - Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid - Google Patents

Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid

Info

Publication number
IL215195A0
IL215195A0 IL215195A IL21519511A IL215195A0 IL 215195 A0 IL215195 A0 IL 215195A0 IL 215195 A IL215195 A IL 215195A IL 21519511 A IL21519511 A IL 21519511A IL 215195 A0 IL215195 A0 IL 215195A0
Authority
IL
Israel
Prior art keywords
ursodeoxycholic acid
nonalcoholic steatohepatitis
treating nonalcoholic
elevated doses
doses
Prior art date
Application number
IL215195A
Other languages
English (en)
Original Assignee
Axcan Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcan Pharma Inc filed Critical Axcan Pharma Inc
Publication of IL215195A0 publication Critical patent/IL215195A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL215195A 2009-03-17 2011-09-18 Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid IL215195A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16095509P 2009-03-17 2009-03-17
PCT/IB2010/000551 WO2010106420A1 (en) 2009-03-17 2010-03-16 Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid

Publications (1)

Publication Number Publication Date
IL215195A0 true IL215195A0 (en) 2011-12-29

Family

ID=42167374

Family Applications (1)

Application Number Title Priority Date Filing Date
IL215195A IL215195A0 (en) 2009-03-17 2011-09-18 Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid

Country Status (12)

Country Link
US (1) US20120071451A1 (enExample)
EP (1) EP2408457A1 (enExample)
JP (1) JP2012520866A (enExample)
KR (1) KR20120008034A (enExample)
CN (1) CN102361642A (enExample)
AU (1) AU2010224587A1 (enExample)
CA (1) CA2755708A1 (enExample)
IL (1) IL215195A0 (enExample)
MX (1) MX2011009757A (enExample)
RU (1) RU2011139643A (enExample)
WO (1) WO2010106420A1 (enExample)
ZA (1) ZA201107578B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
KR101401628B1 (ko) * 2012-12-24 2014-06-02 삼성제약공업주식회사 간기능 개선용 정제 및 그 제조 방법
US9814733B2 (en) * 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
EP3712254A1 (en) 2014-05-28 2020-09-23 Children's Hospital Medical Center Methods and systems for converting precursor cells into gastric tissues through directed differentiation
CA3194562C (en) * 2014-07-29 2026-03-17 Shenzhen Hightide Biopharmaceutical, Ltd. Berberine-ursodeoxycholic salt, method of preparation and application therof
CA2963704A1 (en) 2014-10-17 2016-04-21 Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
PE20180690A1 (es) * 2015-04-27 2018-04-23 Intercept Pharmaceuticals Inc Composiciones de acido obeticolico y metodos de uso
TWI711464B (zh) * 2015-11-19 2020-12-01 欣耀生醫股份有限公司 預防或治療脂肪肝、保護肝功能、或改善脂肪肝引起的肝病變或其他相關病症之組合物及方法
EP4177335A1 (en) 2016-05-05 2023-05-10 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
SG11201903697WA (en) 2016-11-04 2019-05-30 Childrens Hospital Med Ct Liver organoid compositions and methods of making and using same
EP3548507A4 (en) 2016-12-05 2020-07-15 Children's Hospital Medical Center COLON ORGANOIDS AND PROCESSES FOR THE PREPARATION AND USE THEREOF
EP3609997A4 (en) 2017-04-14 2021-03-03 Children's Hospital Medical Center COMPOSITIONS OF STEM CELLS FROM MULTIPLE DONOR CELLS AND THEIR PREPARATION PROCEDURES
CN110958878A (zh) * 2017-06-21 2020-04-03 诺华股份有限公司 用于治疗非酒精性脂肪性肝炎的licofligozin
US12297457B2 (en) 2017-10-10 2025-05-13 Children's Hospital Medical Center Esophageal tissue and/or organoid compositions and methods of making same
KR101887561B1 (ko) * 2017-11-15 2018-09-06 주식회사 대웅제약 간염 바이러스에 의해 유발된 간 섬유화의 개선을 위한 약학 조성물
EP3727394A4 (en) 2017-12-21 2021-09-08 Children's Hospital Medical Center DIGITALIZED HUMAN ORGANOIDS AND METHOD OF USING THEREOF
US12421500B2 (en) 2018-07-26 2025-09-23 Children's Hospital Medical Center Hepato-biliary-pancreatic tissues and methods of making same
RU2686042C1 (ru) * 2018-09-04 2019-04-23 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ лечения неалкогольной жировой болезни печени при метаболическом синдроме
JP2021535753A (ja) 2018-09-12 2021-12-23 チルドレンズ ホスピタル メディカル センター 造血幹細胞およびその派生体の生成のためのオルガノイド組成物
WO2020160371A1 (en) 2019-02-01 2020-08-06 The University Of Hong Kong Innervated organoid compositions and methods of making same
CA3141814A1 (en) 2019-05-31 2020-12-03 Children's Hospital Medical Center Shaped organoid compositions and methods of making same
CN114174494A (zh) 2019-05-31 2022-03-11 儿童医院医学中心 产生和扩增造血干细胞的方法
EP4005578A4 (en) * 2019-07-30 2024-05-01 Kobiolabs, Inc. COMPOSITION AND METHODS FOR PREVENTING, RELIEVING OR TREATING LIVER INJURY
US20220276246A1 (en) * 2019-07-30 2022-09-01 Kobiolabs, Inc. Kit for predicting or diagnosing nonalcoholic fatty liver disease, and method for diagnosing nonalcoholic fatty liver disease
WO2021152430A1 (en) * 2020-01-28 2021-08-05 Shilpa Medicare Limited Method for administration of ursodeoxycholic acid
CN116782898A (zh) * 2020-10-23 2023-09-19 深圳君圣泰生物技术有限公司 小檗碱熊去氧胆酸盐的组合物及其用于治疗脂肪性肝病、糖尿病和高脂血症的方法
CN115137732A (zh) * 2021-03-29 2022-10-04 中国科学院大连化学物理研究所 Gpr120受体激动剂及熊去氧胆酸的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297229B1 (en) * 1994-11-14 2001-10-02 Mayo Foundation For Medical Education And Research Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis

Also Published As

Publication number Publication date
ZA201107578B (en) 2013-06-26
CN102361642A (zh) 2012-02-22
JP2012520866A (ja) 2012-09-10
RU2011139643A (ru) 2013-04-27
WO2010106420A1 (en) 2010-09-23
CA2755708A1 (en) 2010-09-23
AU2010224587A1 (en) 2011-09-22
KR20120008034A (ko) 2012-01-25
MX2011009757A (es) 2012-02-28
US20120071451A1 (en) 2012-03-22
EP2408457A1 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
ZA201107578B (en) Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid
PT2435825E (pt) Métodos para o tratamento de doenças
PT2376077T (pt) Composição e método para tratamento de diabetes
PT2429524T (pt) Formulação de ac220 seca por atomização
IL216951A0 (en) Method for treatment of diseases
EP2453748A4 (en) METHOD OF TREATMENT
EP2480246A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES
TWI369976B (en) Method of assisting radiotherapy and apparatus thereof
IL218230A0 (en) Method of treating cancer
PL2596794T3 (pl) Sposób leczenia różnego pochodzenia chorób wątroby
EP2413698A4 (en) PROCESS FOR TREATING OSTEOPOROSIS
HRP20131121T1 (hr) Postupak za poboljšanje neprozirnosti
GB201020045D0 (en) Method for the treatment of biogas
EP2462131A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH BETA-AMYLOID
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
GB0909807D0 (en) Method of treatment
GB0904164D0 (en) Method of treatment
ZA200907778B (en) Method of treating diabetes
GB0900624D0 (en) Method of treating wool
AU2009903360A0 (en) Method of Treatment
GB0807366D0 (en) Method of process control
GB0823435D0 (en) Method of treatment
GB0914373D0 (en) Treatment method
AU2009904857A0 (en) Method for enhancing biological water treatment